The signing follows the July 2025 Memo of Understanding (MOU) that was signed between PharmaJet, Egypt’s Unified Procurement Agency (UPA) and EVA Pharma, which outlined plans for how UPA could ...
AptarGroup (ATR) posted a robust 24.8% earnings growth over the past year, outpacing its five-year average annual rate of 13.2%. Net profit margin improved to 11.5%, up from 9.4% last year, but ...
Today’s teens are drinking and smoking less, but many are spending more time online, where risky behaviors can be harder for ...
17h
AptarGroup outlines 35% decline in emergency medicine revenue for 2026 amid shifting pharma demand
Get key insights from AptarGroup’s Q3 2025 earnings call—injectables growth, Brazil expansion, and 2026 margin headwinds. See what’s next for ATR.
PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free ...
Investor's Business Daily on MSN
After More Than Tripling, Energy Drink Maker Celsius Hits Latest Buy Point. But Earnings Loom.
Celsius stock hit its latest buy point before retreating. And third-quarter earnings results are due out in early November.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback